middle.news
Cynata Therapeutics Raises A$1.5 Million Placement Ahead of Key Clinical Trial Readouts
9:32am on Wednesday 6th of May, 2026 AEST
•
Healthcare
Read Story
Cynata Therapeutics Raises A$1.5 Million Placement Ahead of Key Clinical Trial Readouts
9:32am on Wednesday 6th of May, 2026 AEST
Key Points
A$1.5 million placement at A$0.25 per share
Funds to support commercial partnerships post-trial results
Phase 3 osteoarthritis data due May 2026
Phase 2 acute GvHD trial results expected June 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cynata Therapeutics (ASX:CYP)
OPEN ARTICLE